logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
H

Hisashi Yamanaka

international university of health & welfare
H指数:80
被引数:2.9万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Efficacy and Safety of Tofacitinib and Adalimumab in Rheumatoid Arthritis by Body Mass Index-Normalized Methotrexate Dose: A Post Hoc Analysis

按体重指数校正的甲氨蝶呤剂量下，托法替尼与阿达木单抗治疗类风湿关节炎的有效性和安全性：一项事后分析

Rheumatology and Therapy
IF2.9
2026-01-220
OAAI
Tsutomu Takeuchi; Yoshiya Tanaka; Hisashi Yamanaka; Kunihiro Yamaoka; Naonobu Sugiyama; Noriko Iikuni; Shigeyuki Toyoizumi; Kenneth Kwok; Wen-Chan Tsai; Eduardo Mysler; Robert J. Moots; Josef S. Smolen; Roy Fleischmann
Factors associated with treatment discontinuation and age-stratified safety of abatacept in Japanese patients with rheumatoid arthritis: 5-year results of the ORIGAMI study

影响日本类风湿关节炎患者阿巴西特治疗中断的因素及按年龄分层的安全性：ORIGAMI研究5年结果

Modern Rheumatology
IF1.9
2026-01-010
OA
Harigai, Masayoshi; Tanaka, Eiichi; Inoue, Eisuke; Misaki, Kenta; Tamura, Naoto; Hirano, Fuminori; Oshikawa, Hideto; Naniwa, Taio; Hirata, Shintaro; Komiya, Takaaki; Kaneko, Kaichi; Suzuki, Yoko; Yoshitama, Tamami; Himeno, Shinkichi; Matsumoto, Shigeru; Yoshizawa, Yuri; Yamanaka, Hisashi
Letter to the Editor Regarding “Evaluation of VTE, MACE, and Serious Infections Among Patients with RA Treated with Baricitinib Compared to TNFi: A Multi-Database Study of Patients in Routine Care Using Disease Registries and Claims Databases”

致编辑函：关于“比较巴瑞替尼与TNFi治疗类风湿关节炎患者中VTE、MACE和严重感染的多数据库常规护理患者研究（利用疾病登记和理赔数据库）”

Rheumatology and Therapy
IF2.9
2025-09-260
OA
Claudia A. Salinas; Anthony Louder; Jennifer Polinski; Tancy C. Zhang; Hannah Bower; Syd Phillips; Yufei Song; Emaan Rashidi; Rafia Bosan; Hsiu-Ching Chang; Nicole Foster; Bernice Gershenson; Hisashi Yamanaka; Mitsumasa Kishimoto; Yoshiya Tanaka; Peter Fischer; Baojin Zhu; Douglas Faries; Xiaodan Mai; Brett T. Doherty; Angela Grelaud; Nicolas H. Thurin; Johan Askling; Walter Deberdt
Efficacy and Safety of E6011, an Anti-Fractalkine Monoclonal Antibody, in Patients With Active Rheumatoid Arthritis With Inadequate Response to Methotrexate: Results of a Randomized, Double-Blind, Placebo-Controlled Phase II Study
ARTHRITIS & RHEUMATOLOGY
IF10.9
2021-02-1816
OAAI
Tanaka, Yoshiya; Takeuchi, Tsutomu; Yamanaka, Hisashi; Nanki, Toshihiro; Umehara, Hisanori; Yasuda, Nobuyuki; Tago, Fumitoshi; Kitahara, Yasumi; Kawakubo, Makoto; Torii, Kentaro; Hojo, Seiichiro; Kawano, Tetsu; Imai, Toshio
Integration of genetics and miRNA-target gene network identified disease biology implicated in tissue specificity
NUCLEIC ACIDS RESEARCH
IF13.1
2018-11-0835
OAAI
Sakaue, Saori; Hirata, Jun; Maeda, Yuichi; Kawakami, Eiryo; Nii, Takuro; Kishikawa, Toshihiro; Ishigaki, Kazuyoshi; Terao, Chikashi; Suzuki, Ken; Akiyama, Masato; Suita, Naomasa; Masuda, Tatsuo; Ogawa, Kotaro; Yamamoto, Kenichi; Saeki, Yukihiko; Matsushita, Masato; Yoshimura, Maiko; Matsuoka, Hidetoshi; Ikari, Katsunori; Taniguchi, Atsuo; Yamanaka, Hisashi; Kawaji, Hideya; Lassmann, Timo; Itoh, Masayoshi; Yoshitomi, Hiroyuki; Ito, Hiromu; Ohmura, Koichiro; Forrest, Alistair R. R.; Hayashizaki, Yoshihide; Carninci, Piero; Kumanogoh, Atsushi; Kamatani, Yoichiro; de Hoon, Michiel; Yamamoto, Kazuhiko; Okada, Yukinori
HLA-DRB1 Analysis Identified a Genetically Unique Subset within Rheumatoid Arthritis and Distinct Genetic Background of Rheumatoid Factor Levels from Anticyclic Citrullinated Peptide Antibodies

HLA-DRB1分析从抗环瓜氨酸肽抗体中鉴定出类风湿性关节炎的遗传独特子集和类风湿因子水平的不同遗传背景

JOURNAL OF RHEUMATOLOGY
IF3.4
2018-02-019
PREAI
Hiwa, Ryosuke; Ikari, Katsunori; Ohmura, Koichiro; Nakabo, Shuichiro; Matsuo, Keitaro; Saji, Hiroh; Yurugi, Kimiko; Miura, Yasuo; Maekawa, Taira; Taniguchi, Atsuo; Yamanaka, Hisashi; Matsuda, Fumihiko; Mimori, Tsuneyo; Terao, Chikashi
Clinical benefit of 1-year certolizumab pegol (CZP) add-on therapy to methotrexate treatment in patients with early rheumatoid arthritis was observed following CZP discontinuation: 2-year results of the C-OPERA study, a phase III randomised trial
ANNALS OF THE RHEUMATIC DISEASES
IF20.6
2017-08-0133
OAAI
Atsumi, Tatsuya; Tanaka, Yoshiya; Yamamoto, Kazuhiko; Takeuchi, Tsutomu; Yamanaka, Hisashi; Ishiguro, Naoki; Eguchi, Katsumi; Watanabe, Akira; Origasa, Hideki; Yasuda, Shinsuke; Yamanishi, Yuji; Kita, Yasuhiko; Matsubara, Tsukasa; Iwamoto, Masahiro; Shoji, Toshiharu; Togo, Osamu; Okada, Toshiyuki; van der Heijde, Desiree; Miyasaka, Nobuyuki; Koike, Takao
Anti-centromere antibody exhibits specific distribution levels among anti-nuclear antibodies and may characterize a distinct subset in rheumatoid arthritis
SCIENTIFIC REPORTS
IF3.9
2017-07-319
OAAI
Kuramoto, Nobuo; Ohmura, Koichiro; Ikari, Katsunori; Yano, Koichiro; Furu, Moritoshi; Yamakawa, Noriyuki; Hashimoto, Motomu; Ito, Hiromu; Fujii, Takao; Murakami, Kosaku; Nakashima, Ran; Imura, Yoshitaka; Yukawa, Naoichiro; Yoshifuji, Hajime; Taniguchi, Atsuo; Momohara, Shigeki; Yamanaka, Hisashi; Matsuda, Fumihiko; Mimori, Tsuneyo; Terao, Chikashi

研究方向

暂未获取到该数据
A
Atsuo Taniguchi
H 指数:46论文数:333被引数:9,112
S
Shigeki Momohara
H 指数:46论文数:337被引数:1.0万
K
Katsunori Ikari
H 指数:40论文数:310被引数:9,007
E
Eisuke Inoue
H 指数:47论文数:360被引数:8,886
E
Eiichi Tanaka
H 指数:56论文数:692被引数:1.6万
Y
Yoshiya Tanaka
H 指数:101论文数:1,688被引数:5.4万
T
Tsutomu Takeuchi
H 指数:98论文数:1,980被引数:5.4万
N
Naoyuki Kamatani
H 指数:71论文数:575被引数:2.1万
A
Ayako Nakajima
H 指数:39论文数:306被引数:5,179
T
Tsuneyo Mimori
H 指数:79论文数:640被引数:2.9万